Filter By Category
Archives
Share on -
ANETUMAB CORIXETAN
Generic Name: ANETUMAB CORIXETAN
ABSTRACT -
Anetumab corixetan is the antibody-chelator component of a mesothelin-targeted thorium-227 radioimmunoconjugate platform. In the radiolabeled product, anetumab, a fully human anti-mesothelin IgG1 antibody, is linked through the corixetan chelator to thorium-227 to deliver targeted alpha radiation to mesothelin-expressing tumor cells.
DOSAGE -
- Dosage should be determined only by a nuclear-medicine oncology specialist within an approved protocol.
- No approved routine dosage is established for general clinical use.
- Radiolabeled dosing is activity-based and trial-specific, with radiation-safety procedures.
- Patients require monitoring for marrow, renal, hepatic, and radiation-related toxicity.
SIDE EFFECTS–
- Possible side effects include:
- Fatigue
- Nausea
- Reduced blood counts
- Injection or infusion reactions
- Laboratory abnormalities
- Abdominal discomfort
- Antidrug antibody formation
- Potential radiation-related tissue toxicity
ALLRGIC REACTIONS–
- Possible allergic reaction symptoms include:
- Rash
- Urticaria
- Facial swelling
- Bronchospasm
- Anaphylaxis symptoms
- Important: Patients who develop an allergic reaction to Anetumab Corixetan should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS–
- Other myelosuppressive anticancer treatments may increase cytopenias.
- Radiopharmaceuticals require careful cumulative radiation assessment.
- Mesothelin-targeted therapies may have overlapping tumor-target effects.
- Live vaccines are generally avoided during significant immunosuppression.
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Use only in authorized oncology/nuclear-medicine facilities.
- Confirm tumor mesothelin expression when required by protocol.
- Monitor blood counts, organ function, and radiation exposure precautions.
- Use effective contraception where required by protocol due to potential reproductive risk.
WARNINGS –
- Investigational radiopharmaceutical platform; not for routine clinical use.
- Radiation exposure and marrow toxicity can be serious.
- Handle only under trained radiation-safety supervision.
- Keep out of reach of children.
Share on -
. Developed by